Systematic review reveals no survival difference between margin analysis techniques in OCSCC, suggesting optimization is needed.
Specimen-based frozen margin analysis in OCSCC results in lower false negative rates and improved local control; however, there is no significant difference in overall recurrence or survival when comparing specimen-based vs tumor bed-based techniques.
No takes yet. Share an insight, caveat, or question.
Caraway et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: